Signati™ Medical, Inc. today announced that it has completed the acquisition of all of the intellectual property and technology of SuperiorVAS, LLC, a privately held company in Raleigh, NC. The IP covers methods to create a vasectomy through ablation of the vas deferens—an advancement in a critical technology. Terms of the agreement were not disclosed. “The acquisition of this advanced technology complements our current pipeline to provide minimally invasive vasectomy procedures. Our focus continues to be our bipolar radio frequency sealing technology for the vasectomy market,” says Bill Prentice, CEO of Signati™ Medical, Inc.
Read the full article: Signati™ Medical, Inc. Completes Acquisition of SuperiorVAS Intellectual Property and Technology //
Source: https://www.globenewswire.com/news-release/2022/12/09/2571086/0/en/Signati-Medical-Inc-Completes-Acquisition-of-SuperiorVAS-Intellectual-Property-and-Technology.html